The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Metabolic Syndrome
NCT ID: NCT03734835
Last Updated: 2018-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2018-04-01
2019-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Non-alcoholic Fatty Liver Disease: A Randomized, Controlled Study
NCT03734510
The Effects of Hesperidin and Flaxseed on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
NCT03377153
Effects of Flaxseed Supplementation in Metabolic Syndrome
NCT02497352
Flaxseed Intervention on Metabolic Syndrome
NCT00733772
The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
NCT02395900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hesperidin and flaxseed
1000 mg hesperidin as two capsules and 30 grams flaxseed
hesperidin and flaxseed
1000 mg hesperidin as two capsules and 30 grams flaxseed
control
no supplementation
control
no supplementation
flaxseed
30 grams flaxseed
flaxseed
30 grams flaxseed
hesperidin
1000 mg hesperidin as two capsules
hesperidin
1000 mg hesperidin as two capsules
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hesperidin
1000 mg hesperidin as two capsules
hesperidin and flaxseed
1000 mg hesperidin as two capsules and 30 grams flaxseed
flaxseed
30 grams flaxseed
control
no supplementation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having 3 of 5 of high blood sugar, hypertension, high TG, high waist circumference, low HD
Exclusion Criteria
* history of Cardiovascular disease, Pulmonary disease, Renal disease \& Celiac disease; Cirrhosis
* Following a program to lose weight in recent 3 mo
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Nutrition and Food Technology Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Azita Hekmatdoost
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Nutrition and Food Technology Research Institute
Tehran, Iran (the Islamic Republic Of), Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Azits Hekmatdoost, MD,PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13678
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.